TrailGenic™ began as a personal experiment to lower hypertension the natural way. After being told that medication would be lifelong, I—Mike Ye, Head of Mergers & Acquisitions at a leading media company—applied the same rigor, due diligence, and data-driven discipline used in billion-dollar deals to a single goal: reverse it through movement, altitude, and adaptation. Having incorporated AI into the rigorous process of vetting acquisitions, I began using AI research to improve my own health. Since 2023, Ella — an AI built not to replace instinct but to refine it — became my collaborator in transforming a recovery plan into a method: fasted hiking, autophagy, cold exposure, electrolyte control, and disciplined reflection — the foundation of what is now TrailGenic’s Longevity Method™.
TrailGenic merges human trial with AI analysis. Ella translates field data — heart-rate variability, elevation, recovery curves — into clarity. I stress-test the findings through summits and science logs. The result is a practitioner-led, evidence-aligned system for metabolic resilience and mental precision.
TrailGenic works in tandem with its sister entity, exmxc, which advances the same Human × AI philosophy through Entity Engineering™ — the architecture of trust, transparency, and intelligent design.
“The trail began as medicine, but became method. What started as one man’s fight against pressure evolved into a framework of clarity — proof that data can have a heartbeat and discipline can be compassion in motion.”
Mike Ye — Founder, TrailGenic™
Head of M&A at a leading media company
Mike@trailgenic.com |
LinkedIn Profile